I.W. Badon, et al.
Journal of Photochemistry & Photobiology A: Chemistry 377 (2019) 214–219
1
1
5
5
61.47, 160.01, 156.01, 135.43, 132.00, 130.11, 121.96, 108.13,
06.93, 101.70, 92.41, 72.02, 71.45, 70.92, 70.75, 70.66, 69.67, 67.78,
19
3
9.13, 42.78, 32.20, 29.74, 27.90, 16.39, 14.49. F NMR (CDCl ,
00 MHz)= -147.10 (m) ppm. 11B NMR (CDC+l
, 400 MHz): δ = 0.410
m/z: calculated for
3
(
t) ppm. MALDI-TOF/TOF MS: [M + Na]
C
58
H
95BF
EtBOD-PEG was synthesized using the same procedure described
above but with ethyl-BODIPY-(CH -Br (40.0 mg, 1.00 eq). All the
other reagents were scaled accordingly, and the crude product was
purified by silica gel column chromatography eluting with CH Cl
MeOH to afford the PEGylated BODIPY as a dark magenta oil. Yield
2 2
N NaO20, 1211.64; found, 1213.713.
2 4
)
2
2
:
1
25%. H NMR (CDCl
3
, 400 MHz): δ = 7.17 (d-s, 2 H), 6.70 (s, 1 H), 4.37
(
t, 2 H), 4.12 (t, 4 H), 3.71-3.63 (m, 52 H), 3.56 (t, 4 H), 3.38 (s, 6 H),
3
1
1
1
6
.07 (m, 2 H), 2.49 (s, 6 H), 2.40 (m, 2 H), 2.33 (s, 6 H), 2.05 (m, 2 H),
.99 (t, 2 H), 1.03 (t, 6 H) ppm. 13C NMR (CDCl
66.45, 160.02, 152.55, 144.06, 138.63, 135.75, 132.91, 132.06,
31.05, 108.18, 106.82, 100.06, 72.03, 71.46, 70.92, 70.76, 69.67,
3
, 300 MHz): δ 187.42,
7.78, 59.14, 42.79, 29.75, 29.18, 17.19, 16.09, 14.86, 13.37, 12.43.
1
9
11
3
F NMR (CDCl3, 500 MHz): δ = -146.43 (m) ppm. B NMR (CDCl ,
+
400 MHz): δ = 0.458 (t) ppm. MALDI-TOF/TOF MS: [M + Na] m/z:
2 2
calculated for C62H103BF N
NaO20, 1267.71; found, 1267.786.
2.6. Cell proliferation assay
The human breast MCF-7 cells (3 × 103 cells/well) were seeded in
6-well plates. After the cells were maintained for 24 h, cells were
9
treated with either BOD-PEG or EtBOD-PEG dye for 24 h. Cell pro-
liferation assay was measured using CellTiter 96 ® AQueous One
Solution Cell Proliferation Assay (Promega, Madison, WI, USA) ac-
cording to the manufacturer's instruction. This assay contains MTS [3-
Fig. 6. The relative number of viable cells after incubation with different
concentrations of BOD-PEG (top) and EtBOD-PEG (bottom) dyes for 24 h.
(
4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfo-
cold water and extracted with dichloromethane three (3) times. The
organic layer was washed with water and brine, and dried over MgSO ,
4
following which the solvent was removed by rotary evaporation. The
phenyl)-2H-tetrazolium] which is reduced to formazan by the action of
NADH or NADPH in metabolically active cells [27]. The absorbance
value of the wells containing solutions of MTS (background) was sub-
tracted from those of the wells containing the treated and control cells.
crude product was purified by silica gel column chromatography using
1
CH
2
Cl
2
and MeOH as eluent. Yield 53%. H NMR (CDCl
3
, 400 MHz):
δ = 7.20 (s, 2 H), 6.69 (s, 1 H), 4.37 (m, 2 H), 4.16 (t, 4 H), 3.76-3.60
2.7. Confocal microscopy
(
m, 52 H), 3.54 (t, 4 H), 3.38 (s, 6 H), 1.38 (t, 3 H) ppm.
MCF-7 cells were grown on sterilized coverslips in 12-well overnight
and then treated with either BOD-PEG or EtBOD-PEG dye for 24 h.
After washing with phosphate-buffered saline (PBS), cells were fixed
with 4% paraformaldehyde for 60 min and permeabilized with 0.5%
Triton X-100 for 10 min. at room temperature. The slides were mounted
with Vectashield mounting medium with 4′,6-Diamidino-2-pheny-
lindole (DAPI) (Vector Laboratories, Burlingame, CA, USA) following
the manufacturer's instructions. Images were captured with a confocal
microscope at 20× magnification (LSM-700; Carl Zeiss Microimaging
Inc., Stockholm, Sweden).
2
.4. Synthesis of 3,5-dialkoxy benzoic acid
In a THF-H O (1:1) mixed solvent system, ethyl-3,5-dialkoxy
2
benzoate (3.47 g, 1.00 eq) and sodium hydroxide (0.473 g, 3.00 eq)
were dissolved and refluxed for 24 h at 80 °C. After the solution cools to
room temperature, the pH was adjusted to 3–4 using 10% v/v HCl.
Then it was extracted using CH
via rotary evaporation to afford a brown oil. Yield 13%. H NMR
CDCl
2 2 4
Cl , dried over MgSO and concentrated
1
(
3
3
, 400 MHz): δ = 7.25 (s, 2 H), 6.70 (s, 2 H), 4.16 (t, 4 H), 3.71-
.65 (m, 52 H), 3.57 (m, 4 H), 3.38 (s, 6 H) ppm.
3. Results and discussion
2.5. Synthesis of PEGylated BODIPYs
3.1. Synthesis of PEGylated BODIPY dyes
To KOH (5.00 mg, 1.00 eq) dissolved in MeOH, 3,5-dialkoxy benzoic
acid (150 mg, 2.00 eq) was added and stirred. Then the solvent was
completely removed to obtain potassium 3,5-dialkoxy benzoate.
Fig. 1 outlines the synthesis of the fluorescent BODIPY dyes con-
taining di-branched PEG chains. The di-branched PEG chains were
prepared according to previously reported methods. [26] First, Wil-
liamson etherification between ethyl 3,5-dihydroxybenzoate and tosy-
lated PEG produced di-PEGylated benzoates. Their subsequent hydro-
lysis yielded di-PEGylated benzoic acid. Meso-1-bromo-butyl-
substituted BODIPY dyes were prepared via the condensation of 5-
bromovaleryl chloride with either 2,4-dimethyl-3-ethylpyrrole or 2,4-
BODIPY-(CH
2 4
) -Br (43.0 mg, 20 eq), potassium 3,5-dialkoxy benzoate
(
200 mg, 40 eq) and tetrabutylammonium bromide (1.81 mg, 1 eq)
were dissolved in anhydrous DMF and refluxed at 40 °C for 48 h. After
cooling to room temperature, the solvent was vacuum distilled, and the
crude product was purified by silica gel column chromatography
eluting with CH
2
Cl
2
: MeOH to afford BOD-PEG dye as a dark orange
oil. Yield 17%. H NMR (CDCl , 400 MHz): δ = 7.16 (d-s, 2 H), 6.69 (s,
H), 6.06 (s, 2 H), 4.36 (t, 2 H), 4.12 (t, 4 H), 3.69-3.64 (m, 52 H), 3.54
t, 4 H), 3.38 (s, 6 H), 3.03(m, 2 H), 2.51 (s, 6 H), 2.41 (s, 6 H), 1.96 (m,
3 2
dimethylpyrrole and subsequent complexation with BF ·OEt in the
1
3
presence of triethylamine. Finally, the esterification between the bro-
mine-containing BODIPYs and the carboxyl ends of the di-PEGylated
benzoic acid afforded the water-soluble BODIPY dyes in moderate
yields; 16.6% and 25.2% for BOD-PEG and EtBOD-PEG, respectively.
1
(
1
3
2
3
H), 1.80 (m, 2 H) ppm. C NMR (CDCl , 300 MHz): δ 186.30, 177.96,
217